Need an oil spill lawyer? We will fight for you!
› $4.85 Billion settlement in drug case
The number of bloggers out there writing about their personal experiences with Chantix and documenting, for the world to see, the musings of a mind tortured by nicotine withdrawal, seems to be proliferating even as prescriptions for the smoking cessation drug decline. Now it appears that a new genre in world of Chantix information has emerged: the Comical Side Effect.
According to The Institute for Safe Medicine Practices (ISMP), the number of drug-related adverse events and deaths reported to the Food and Drug Administration has hit a record level. Numbers pulled from the FDA’s Adverse Event Reporting System (AERS) reveal that Heparin and Chantix are largely to blame for the upward swing.
Researchers at the Institute for Safe Medicine Practices, a nonprofit organization, and Wake Forest University say that their latest review of Chantix data justifies stepping up warnings about the drug.
More than 1,000 complications were reported in the first quarter of 2008, including 15 traffic accidents, 52 incidents of loss of consciousness and blackouts, and 50 deaths.
Reports of adverse effects among users taking Chantix were greater than any other prescription drug for the second quarter in a row.
Yesterday I wrote about the non-psychiatric side effects of Chantix and how studies are beginning to reveal how those side effects can adversely affect one’s driving. Loss of consciousness, dizziness, confusion, aggression, and muscle spasms can all happen to a Chantix user who is behind the wheel. I don’t mean to sound alarmist, but I have had enough first-hand experience with Chantix to know these newest warnings are worth emphasizing.
By now we know that Chantix is dangerous for some people who use the drug, but mounting evidence suggests that people who don’t use it may also be harmed. Since Chantix became available for smoking cessation in August of 2006, the FDA has received a steady influx of reports connecting the drug to traffic accidents. Moreover, while the medical community and the media are focused on the negative psychiatric effects that some Chantix users experience, researchers now believe that the non-psychiatric effects may be worse.
Many medical researchers find little surprise that Chantix has been linked to higher than normal rates of depression and suicide. Varenicline (the chemical name of Pfizer’s smoking cessation drug) goes to work directly in the brain by targeting certain receptors and simulating that feeling of having already smoked – that “full” feeling smokers feel after they’ve lit up one or two. Other pharmaceuticals that go to work directly in the brain include antidepressants, some of which have also been linked to behavioral problems and suicide.
Next week, Pfizer will once again be running Chantix ads on television. Pfizer stopped running Chantix ads last year amid increasing concern over the drug’s side effects. The familiar tortoise and the hare ads will resume on Sunday, September 14, with lengthened warnings about potential side effects. The extended warnings will occupy 41 seconds of the ad, which will run for 90 seconds – 30 seconds longer than the old ads.
Following the release of the U.S. Food & Drug Administration (FDA) public health advisory on Chantix in May, the Federal Motor Carrier Safety Administration all but outright banned the use of Chantix for commercial drivers.
According to a report in today’s Stars & Stripes, a daily newspaper published for the U.S. military, Department of Defense (DoD) civilians, contractors and their families, the anti-smoking medication Chantix (varenicline) has been pulled from at least one military pharmacy following reports of serious adverse reactions.
Smoking cessation today isn’t as simple as it used to be. Years ago, smokers had a couple of choices: cold turkey or hypnotherapy. Then, as awareness about the dangers of smoking grew, thanks to efforts by the government and independent health groups, so too did the number of smoking cessation aids. First came prescription-only nicotine gum, which was quickly succeeded by a procession-soon-to-be-explosion of over-the-counter therapeutic nicotine — gum, patches, lozenges. In 1997, the FDA approved bupropion (a.k.a. Zyban/Wellbutrin) for use in smoking cessation. Meanwhile, all sorts of gadgets and gimmicks flooded the market. And then came Chantix.
![[ Beasley Allen Law Firm Logo ]](http://www.chantix-legal.com/wp-content/themes/system-unity/images/logo.png){kind=logo}